- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT05760001
O estudo IGNITE for Kids sobre investimento concentrado em bairros negros e saúde e bem-estar infantil
Um ensaio controlado randomizado de investimento concentrado em bairros negros para abordar o racismo estrutural como uma causa fundamental da saúde infantil precária
Black children and adults in the United States fare worse across nearly every health indicator compared to White individuals. In Philadelphia, the location of this study, these health disparities result in a stark longevity gap, with average life expectancies in poor, predominantly Black neighborhoods being 20 years lower than in nearby affluent, predominantly White neighborhoods. The investigators will conduct a cluster randomized controlled trial (RCT) of a suite of place- based and financial-wellbeing interventions at the community, organization, and individual/household levels that address the social determinants of racial health disparities. At the community level, the investigators address underinvestment in Black neighborhoods by implementing vacant lot greening, abandoned house remediation, tree planting, and trash cleanup. At the organization level, the investigators partner with community-based financial empowerment providers to develop cross-organizational infrastructure to increase reach and maximize efficiency. At the individual/household levels, the investigators increase access to public benefits, financial counseling and tax preparation services, and emergency cash assistance. The investigators will test this "big push" intervention in 60 Black neighborhood micro-clusters, with a total of 480 children. The investigators hypothesize that this "big push" intervention will have significant impact on children's health and wellbeing.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Black individuals in the United States fare worse than White individuals across almost every social, economic, and health indicator. The Black health disadvantage starts at birth, reflecting the cumulative toll of racialized social stressors and healthcare discrimination on maternal health and resulting in higher rates of pre-term birth and low birth weight. Black youth are disproportionately exposed to environmental toxins such as lead and adverse childhood events such as financial hardship and neighborhood violence. Black children also have higher rates of chronic disease, including asthma and diabetes. These and other forces result in inequities in child health and well-being and can also impact children's educational and earning potential. Furthermore, these inequities culminate in a stark racial longevity gap: in Philadelphia, the location of this study, life expectancy for people living in a poor, predominantly Black neighborhood is 20 years lower than for people living in a nearby affluent, predominantly White neighborhood.
The fundamental cause of these striking and pervasive disparities is structural racism - the confluence of deep historical, institutional, cultural, and ideological forces that unequally distribute resources and risks across racialized groups. Structural racism patterns health by affecting a range of interconnected, mutually reinforcing social determinants of health at the national, neighborhood, household, and individual levels. Most notably, longstanding, systematic disinvestment has resulted in highly segregated Black neighborhoods with dilapidated environmental conditions and severe economic insecurity within Black households, leading to a "feedback loop of concentrated racial disadvantage," all of which have been strongly tied to poor health.
Most interventions seeking to address racial health disparities focus on individual-level behaviors and outcomes, or individual channels by which structural racism harms health. However, by failing to address upstream social determinants, these interventions have had limited population level impact. A multi-level, multi-component intervention package focused on a range of social determinants of health is necessary to meaningfully address structural racism as a fundamental cause of racial health disparities. In this trial, we aim to implement such a multi-level, multi-component intervention and then evaluate its impact on child health and well-being.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Estados Unidos, 19104
- University of Pennsylvania
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Child is between the ages of 3 and 17 years at the start of the trial (between the ages of 5 and 19 years at the end of the trial)
- Parent/caregiver is at least 18 years of age
- Parent/caregiver has the ability to communicate via text messaging
- Parent/caregiver is comfortable communicating in English
- Child is a permanent resident of the home where they are to be enrolled
- Parent/caregiver has knowledge of their household finances
Exclusion Criteria:
- Children who plan to move out of the study microcluster within 6 months
- Children whose caregivers are unable to fully consent and participate based on CC team assessment
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Intervention Arm
At the individual level, participants in the intervention arm will receive place-based and financial well-being interventions. These will include, at the individual level:
At the neighborhood level:
|
Financial well-being interventions: • Tax preparation; access to public benefits; financial counseling and microgrants Place-based interventions: • Vacant lot greening; abandoned house remediation; trash cleanup; tree planting |
|
Sem intervenção: Control Arm
Participants in the control arm will not receive any of the listed interventions |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Child Health Questionnaire Parent Form 28 (CHQ-PF28) Composite Score
Prazo: 24 months
|
Composite index using CHQ-28 scoring method, based on a series of 28 questions focused on overall child health, activity limitation, emotional/behavioral difficulties, mood, relationships, and family cohesion. (Child Health Questionnaire) |
24 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Parent-reported child health
Prazo: 24 months
|
(5-pt Likert ranging from poor to excellent) (Child Health Questionnaire) |
24 months
|
|
Caregiver-reported child health care utilization, well child visits
Prazo: 24 months
|
Well child visits in previous 12 months (National Survey of Children's Health) |
24 months
|
|
Caregiver-reported child health care utilization, sick clinic visits
Prazo: 24 months
|
Sick clinic visits in previous 12 months (National Survey of Children's Health) |
24 months
|
|
Caregiver-reported child health care utilization, emergency room visits
Prazo: 24 months
|
Emergency room visits in previous 12 months (National Survey of Children's Health) |
24 months
|
|
Caregiver-reported child health care utilization, hospitalization
Prazo: 24 months
|
Hospitalizations in previous 12 months (National Survey of Children's Health) |
24 months
|
|
Forgone health care
Prazo: 24 months
|
Caregiver report of whether the child needed but did not receive medical, mental health, dental, or vision care in the previous 12 months (National Survey of Children's Health) |
24 months
|
|
Uninsurance or gaps in insurance
Prazo: 24 months
|
Uninsurance or gaps in insurance in the previous 12 months (National Survey of Children's Health) |
24 months
|
|
School attendance
Prazo: 24 months
|
School attendance, based on Philadelphia school district data (Proportion of school days attended, internally developed) |
24 months
|
|
School performance
Prazo: 24 months
|
School performance, based on Philadelphia school district data (Grade point average over previous 12 months, internally developed) |
24 months
|
|
Rate of preterm birth
Prazo: 24 months
|
Rate of preterm birth (birth < 37 weeks of gestation age), based on Pennsylvania birth certificate data |
24 months
|
|
Rate of low birthweight
Prazo: 24 months
|
Rate of low birthweight (birthweight <2000 grams), based on Pennsylvania birth certificate data |
24 months
|
|
Health care utilization: emergency room visits in the previous 12mon
Prazo: 24 months
|
Monthly or quarterly data from 2 years prior to enrollment through approximately 1 year after from HealthShare Exchange |
24 months
|
|
Health care utilization: hospitalizations
Prazo: 24 months
|
Health care utilization: hospitalizations in the previous 12 months, based on Children's Hospital of Philadelphia EHR data |
24 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Eugenia South, MD, MSHP, University of Pennsylvania
- Investigador principal: Aditi Vasan, MD, MSHP, Children's Hospital of Philadelphia
- Investigador principal: Atheendar Venkataramani, MD, PhD, University of Pennsylvania
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 850178b
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .